SlideShare a Scribd company logo
ADVERSE EVENT REPORTING
OF MEDICAL DEVICES
Presented By:
Tanisha Jain
2308212170005
>
<
Guided By:
Mrs. Khyati Patel
Assistant Professor
>
<
INTRODUCTION
ADVERSE EVENT
REPORTING OF MEDICAL
DEVICE
OBJECTIVES
ABOUT EVENTS
TABLE
OF
CONTENTS
2
>
<
3
WHO CAN REPORT?
WHOM TO REPORT?
TIMING TO REPORT?
TIMEFRAME FOR
REPORT?
MDAE FORM
>
<
INTRODUCTION:
Medical Device: A medical device can be any
instrument, apparatus, implement, machine,
appliance, implant, reagent for in vitro use,
software, material or other similar or related
article, intended by the manufacturer to be used,
alone or in combination for a medical purpose.
4
>
<
INTRODUCTION:
Classification of MD (CDSCO)
5
>
<
INTRODUCTION:
Classification of MD (USFDA)
Medical Devices
Risk-Based
Classifications
Class I
Low Risk
Eg: Bandages
Class II Moderate Risk
Eg: Nebulizers
Class III High Risk
Eg: Pacemakers
6
>
<
INTRODUCTION:
Classification of MD (EU)
Medical Devices
Risk-Based
Classifications
Class I
Low Risk
Eg: Wheelchair
Class IIa
Moderate Risk
Eg: Hearing
Aids
Class IIb
Potential Risk
Eg: Infusion
Pumps
Class III
High Risk
Eg: Stunt grafts
7
>
<
Adverse Event Reporting of Medical
Device:
 Adverse Event includes undesirable medical
condition that can be symptoms (nausea, chest
pain), signs (tachycardia, enlarged liver) or the
abnormal results of an investigation (laboratory
findings, electrocardiogram).
 Adverse Events are not necessarily caused by the
medication – the event just needs to have occurred
after taking a medicine. 8
>
<
OBJECTIVES:
• Importance of monitoring patients for an adverse
event.
• Identify the common causes of an adverse event.
• Review the management of an adverse event.
• Review the outcomes for patients affected by an
adverse event.
9
>
<
ABOUT EVENTS:
 An Event has Occurred
The manufacturer becomes aware of information
regarding an event which has occurred with its
device.
10
>
<
ABOUT EVENTS:
Typical events are:
a) A malfunction or deterioration in the characteristics or
performance.
b) An incorrect or out of specification test result.
c) The discovery of a design flaw during design review.
d) An inaccuracy in the labelling, instructions for use
and/or promotional materials.
11
>
<
ABOUT EVENTS:
 The Manufacturer’s Device is Associated with
the Event.
• Complaint trends
• History of previous similar events.
• Information collected from healthcare professional
about the event.
12
>
<
ABOUT EVENTS:
 The Event Led to One of the Following Outcomes:
• Death of a Patient, User
• Serious Injury of a Patient, User
• No death or serious injury occurred but the event
might lead to death or serious injury of a patient,
User or Other Person if the event reoccurs.
13
>
<
ABOUT EVENTS:
 Examples of Reportable Events:
• Loss of sensing after a pacemaker has reached end of life.
• Adverse reaction of an orthopaedic implant due to
loosening.
• A batch of out-of-specification blood glucose test strips is
released. Patient uses strips according to instructions, but
readings provide incorrect values leading to incorrect
insulin dosage, resulting in hypoglycaemic shock and AE.
• Unprotected ECG cable plugged into the main electricity
supply – patient died.
14
>
<
WHO CAN REPORT?
• All healthcare clinicians, pharmacists, nurses &
patients, biomedical/clinical engineers, hospital
technology managers /technicians
15
>
<
WHOM TO REPORT?
• Adverse Events must be reported to a regulatory
Authority according to applicable requirements in
each jurisdiction.
• Regulatory Authorities should provide a contact
point to manufacturers for reporting.
16
>
<
TIMING FOR REPORTING:
• All other reportable events must be reported as soon
as possible by the manufacturer, but not later than
30-elapsed calendar days following the date of
awareness of the event.
• If after becoming aware of a potentially reportable
adverse event, there is still uncertainty about
whether the event is reportable, the manufacturer
must submit a report within the timeframe required
for that type of event.
17
>
<
TIMING FOR REPORTING:
• All report times refer to when the authority must
first be notified.
• This notification may be in the form of an initial
report, final report or trend report as required.
• If additional information is required, the
manufacturer should provide a follow-up or final
report as soon as the information is available or as
requested by the authority. 18
>
<
TIMEFRAME FOR REPORTING:
19
Reporter What to Report To Whom When
Manufacturers Medical device adverse event
(MDAE) or incident on
MDAE reporting form with
causality assessment report.
MvPI Within 30 calendar days
of becoming aware of an
event.
Manufacturers Reports for an event on
MDAE reporting form with
remedial action to prevent an
unreasonable risk of
substantial harm to public
health.
MvPI Within 5 work days of
becoming aware of an
event.
Healthcare service
provider
Medical device adverse event
or incident on MDAE
reporting form with causality
assessment report.
MvPI MDAE reporting form
within 5 work days of
becoming aware and root
cause analysis in next 30
calendar days.
>
<
MDAE FORM:
20
>
<
MDAE FORM:
21
>
<
REFERENCES:
22
GHTF/SG2/N54R8:2006 FINAL DOCUMENT Global
Harmonization Task Force Title: Medical Devices Post
Market Surveillance: Global Guidance for Adverse Event
Reporting for Medical Devices.
>
<
THANK YOU!!!
23

More Related Content

What's hot

GLOBAL MEDICAL DEVICES NOMENCLATURE.pptx
GLOBAL MEDICAL DEVICES NOMENCLATURE.pptxGLOBAL MEDICAL DEVICES NOMENCLATURE.pptx
GLOBAL MEDICAL DEVICES NOMENCLATURE.pptx
SanthiNori1
 
NSF International and its role in Dietary supplements & Nutraceutical industr...
NSF International and its role in Dietary supplements & Nutraceutical industr...NSF International and its role in Dietary supplements & Nutraceutical industr...
NSF International and its role in Dietary supplements & Nutraceutical industr...
SyedArshiya4
 
Plasma master file
Plasma master filePlasma master file
Plasma master file
Sridhar S
 
21 CFR 820 and 801 pptx.pdf
21 CFR 820 and 801 pptx.pdf21 CFR 820 and 801 pptx.pdf
21 CFR 820 and 801 pptx.pdf
BhavikaAPatel
 
Post Marketing Requirements/Complaince: PMRs and PMCs
Post Marketing Requirements/Complaince: PMRs and PMCsPost Marketing Requirements/Complaince: PMRs and PMCs
Post Marketing Requirements/Complaince: PMRs and PMCs
Dr. Reena Malik
 
International Medical Device Regulators Forum
International Medical Device Regulators ForumInternational Medical Device Regulators Forum
International Medical Device Regulators Forum
SanthiNori1
 
STED
STEDSTED
Drug approval process in japan
Drug approval process in japanDrug approval process in japan
Drug approval process in japan
Manish kumar
 
Development and Regulatory Approval of Biologics in European Union (Investiga...
Development and Regulatory Approval of Biologics in European Union (Investiga...Development and Regulatory Approval of Biologics in European Union (Investiga...
Development and Regulatory Approval of Biologics in European Union (Investiga...
Parul Institute of Pharmacy
 
Organization structure of EMA and EDQM active Substance Master File.pptx
Organization structure of EMA and EDQM active Substance Master File.pptxOrganization structure of EMA and EDQM active Substance Master File.pptx
Organization structure of EMA and EDQM active Substance Master File.pptx
BhavikaAPatel
 
US FDA Food Safety Modernization Act final.ppt
US FDA Food Safety Modernization Act final.pptUS FDA Food Safety Modernization Act final.ppt
US FDA Food Safety Modernization Act final.ppt
Lokesh Kothari
 
Post marketing surveillance in Japan, legislation and.pptx
Post marketing surveillance in Japan, legislation and.pptxPost marketing surveillance in Japan, legislation and.pptx
Post marketing surveillance in Japan, legislation and.pptx
Dimple Marathe
 
GMP for Nutraceuticals .pdf
GMP for Nutraceuticals  .pdfGMP for Nutraceuticals  .pdf
GMP for Nutraceuticals .pdf
BhavikaAPatel
 
GHTF Group 1
GHTF  Group 1GHTF  Group 1
GHTF Group 1
RichaTrivedi16
 
Clinical Research Regulation in European Union
Clinical Research Regulation in European Union Clinical Research Regulation in European Union
Clinical Research Regulation in European Union
ShantanuThakre3
 
INVESTIGATIONAL DEVICE EXEMPTIONS.pptx
INVESTIGATIONAL DEVICE EXEMPTIONS.pptxINVESTIGATIONAL DEVICE EXEMPTIONS.pptx
INVESTIGATIONAL DEVICE EXEMPTIONS.pptx
PrachiSharma575050
 
Labeling/Advertising and Promotion, Import/Export, and Enforcement Actions
Labeling/Advertising and Promotion, Import/Export, and Enforcement ActionsLabeling/Advertising and Promotion, Import/Export, and Enforcement Actions
Labeling/Advertising and Promotion, Import/Export, and Enforcement Actions
Michael Swit
 
Nsf standard
Nsf standardNsf standard
Nsf standard
Rx vidhi Ramani
 
Comparison of Clinical Trial Application requirement of India, USA and Europe.
Comparison of Clinical Trial Application requirement of India, USA and Europe.Comparison of Clinical Trial Application requirement of India, USA and Europe.
Comparison of Clinical Trial Application requirement of India, USA and Europe.
Aakashdeep Raval
 
Regulatory requirnment and approval procedure of drugs in japan ppt
Regulatory requirnment and approval procedure of drugs in japan pptRegulatory requirnment and approval procedure of drugs in japan ppt
Regulatory requirnment and approval procedure of drugs in japan ppt
sandeep bansal
 

What's hot (20)

GLOBAL MEDICAL DEVICES NOMENCLATURE.pptx
GLOBAL MEDICAL DEVICES NOMENCLATURE.pptxGLOBAL MEDICAL DEVICES NOMENCLATURE.pptx
GLOBAL MEDICAL DEVICES NOMENCLATURE.pptx
 
NSF International and its role in Dietary supplements & Nutraceutical industr...
NSF International and its role in Dietary supplements & Nutraceutical industr...NSF International and its role in Dietary supplements & Nutraceutical industr...
NSF International and its role in Dietary supplements & Nutraceutical industr...
 
Plasma master file
Plasma master filePlasma master file
Plasma master file
 
21 CFR 820 and 801 pptx.pdf
21 CFR 820 and 801 pptx.pdf21 CFR 820 and 801 pptx.pdf
21 CFR 820 and 801 pptx.pdf
 
Post Marketing Requirements/Complaince: PMRs and PMCs
Post Marketing Requirements/Complaince: PMRs and PMCsPost Marketing Requirements/Complaince: PMRs and PMCs
Post Marketing Requirements/Complaince: PMRs and PMCs
 
International Medical Device Regulators Forum
International Medical Device Regulators ForumInternational Medical Device Regulators Forum
International Medical Device Regulators Forum
 
STED
STEDSTED
STED
 
Drug approval process in japan
Drug approval process in japanDrug approval process in japan
Drug approval process in japan
 
Development and Regulatory Approval of Biologics in European Union (Investiga...
Development and Regulatory Approval of Biologics in European Union (Investiga...Development and Regulatory Approval of Biologics in European Union (Investiga...
Development and Regulatory Approval of Biologics in European Union (Investiga...
 
Organization structure of EMA and EDQM active Substance Master File.pptx
Organization structure of EMA and EDQM active Substance Master File.pptxOrganization structure of EMA and EDQM active Substance Master File.pptx
Organization structure of EMA and EDQM active Substance Master File.pptx
 
US FDA Food Safety Modernization Act final.ppt
US FDA Food Safety Modernization Act final.pptUS FDA Food Safety Modernization Act final.ppt
US FDA Food Safety Modernization Act final.ppt
 
Post marketing surveillance in Japan, legislation and.pptx
Post marketing surveillance in Japan, legislation and.pptxPost marketing surveillance in Japan, legislation and.pptx
Post marketing surveillance in Japan, legislation and.pptx
 
GMP for Nutraceuticals .pdf
GMP for Nutraceuticals  .pdfGMP for Nutraceuticals  .pdf
GMP for Nutraceuticals .pdf
 
GHTF Group 1
GHTF  Group 1GHTF  Group 1
GHTF Group 1
 
Clinical Research Regulation in European Union
Clinical Research Regulation in European Union Clinical Research Regulation in European Union
Clinical Research Regulation in European Union
 
INVESTIGATIONAL DEVICE EXEMPTIONS.pptx
INVESTIGATIONAL DEVICE EXEMPTIONS.pptxINVESTIGATIONAL DEVICE EXEMPTIONS.pptx
INVESTIGATIONAL DEVICE EXEMPTIONS.pptx
 
Labeling/Advertising and Promotion, Import/Export, and Enforcement Actions
Labeling/Advertising and Promotion, Import/Export, and Enforcement ActionsLabeling/Advertising and Promotion, Import/Export, and Enforcement Actions
Labeling/Advertising and Promotion, Import/Export, and Enforcement Actions
 
Nsf standard
Nsf standardNsf standard
Nsf standard
 
Comparison of Clinical Trial Application requirement of India, USA and Europe.
Comparison of Clinical Trial Application requirement of India, USA and Europe.Comparison of Clinical Trial Application requirement of India, USA and Europe.
Comparison of Clinical Trial Application requirement of India, USA and Europe.
 
Regulatory requirnment and approval procedure of drugs in japan ppt
Regulatory requirnment and approval procedure of drugs in japan pptRegulatory requirnment and approval procedure of drugs in japan ppt
Regulatory requirnment and approval procedure of drugs in japan ppt
 

Similar to ADVERSE EVENT REPORTINGOF MEDICAL DEVICE

Medical device-consumer-workshop
Medical device-consumer-workshopMedical device-consumer-workshop
Medical device-consumer-workshop
TGA Australia
 
Safety monitoring and reporting of adverse events of medical devices national...
Safety monitoring and reporting of adverse events of medical devices national...Safety monitoring and reporting of adverse events of medical devices national...
Safety monitoring and reporting of adverse events of medical devices national...
Vivek Nayak
 
Medical device reporting 27 sep2016
Medical device reporting 27 sep2016Medical device reporting 27 sep2016
Medical device reporting 27 sep2016
Ann-Marie Roche
 
Presentation: Increasing post-market vigilance requirements for medical devices
Presentation: Increasing post-market vigilance requirements for medical devicesPresentation: Increasing post-market vigilance requirements for medical devices
Presentation: Increasing post-market vigilance requirements for medical devices
TGA Australia
 
Presentation: Medical Devices: how to stay included workshop - Adverse event ...
Presentation: Medical Devices: how to stay included workshop - Adverse event ...Presentation: Medical Devices: how to stay included workshop - Adverse event ...
Presentation: Medical Devices: how to stay included workshop - Adverse event ...
TGA Australia
 
Sponsor Information and Training day Session A3 - Medical Devices: Post-marke...
Sponsor Information and Training day Session A3 - Medical Devices: Post-marke...Sponsor Information and Training day Session A3 - Medical Devices: Post-marke...
Sponsor Information and Training day Session A3 - Medical Devices: Post-marke...
TGA Australia
 
Devices Sponsor Information Day: 5 - Post-market - Adverse events and monitor...
Devices Sponsor Information Day: 5 - Post-market - Adverse events and monitor...Devices Sponsor Information Day: 5 - Post-market - Adverse events and monitor...
Devices Sponsor Information Day: 5 - Post-market - Adverse events and monitor...
TGA Australia
 
SPONTANEOUS REPORTING SYSTEM & GUIDELINES FOR ADR REPORTING.pptx
SPONTANEOUS REPORTING SYSTEM & GUIDELINES FOR ADR REPORTING.pptxSPONTANEOUS REPORTING SYSTEM & GUIDELINES FOR ADR REPORTING.pptx
SPONTANEOUS REPORTING SYSTEM & GUIDELINES FOR ADR REPORTING.pptx
ashharnomani
 
Presentation: Life cycle of medical devices
Presentation: Life cycle of medical devicesPresentation: Life cycle of medical devices
Presentation: Life cycle of medical devices
TGA Australia
 
Presentation: Therapeutic Goods Administration: An introduction to the work o...
Presentation: Therapeutic Goods Administration: An introduction to the work o...Presentation: Therapeutic Goods Administration: An introduction to the work o...
Presentation: Therapeutic Goods Administration: An introduction to the work o...
TGA Australia
 
Presentation: Patient implant cards and information leaflets – implementation
Presentation: Patient implant cards and information leaflets – implementationPresentation: Patient implant cards and information leaflets – implementation
Presentation: Patient implant cards and information leaflets – implementation
TGA Australia
 
PATIENT SAFETY
PATIENT SAFETYPATIENT SAFETY
PATIENT SAFETY
sunilchaudhary72
 
Presentation: MMDR reform - Patient Implant Cards and Information Leaflets
Presentation: MMDR reform - Patient Implant Cards and Information LeafletsPresentation: MMDR reform - Patient Implant Cards and Information Leaflets
Presentation: MMDR reform - Patient Implant Cards and Information Leaflets
TGA Australia
 
The regulation of medical devices in Australia
The regulation of medical devices in AustraliaThe regulation of medical devices in Australia
The regulation of medical devices in Australia
TGA Australia
 
Safety Monitoring and Reporting in Clinical Trials DIA Poster 2015
Safety Monitoring and Reporting in Clinical Trials DIA Poster 2015Safety Monitoring and Reporting in Clinical Trials DIA Poster 2015
Safety Monitoring and Reporting in Clinical Trials DIA Poster 2015
KCR
 
Fda med watch
Fda med watchFda med watch
Fda med watch
Sridhar S
 
IMPACT OF APPLYING INTERNATIONAL QUALITY STANDARDS ON MEDICAL EQUIPMENT IN SA...
IMPACT OF APPLYING INTERNATIONAL QUALITY STANDARDS ON MEDICAL EQUIPMENT IN SA...IMPACT OF APPLYING INTERNATIONAL QUALITY STANDARDS ON MEDICAL EQUIPMENT IN SA...
IMPACT OF APPLYING INTERNATIONAL QUALITY STANDARDS ON MEDICAL EQUIPMENT IN SA...
ijcax
 
Postmarket monitoring of therapeutic goods in Australia
Postmarket monitoring of therapeutic goods in AustraliaPostmarket monitoring of therapeutic goods in Australia
Postmarket monitoring of therapeutic goods in Australia
TGA Australia
 
ADR reporting (Clinical Research & Pharmacovigilance).pptx
ADR reporting (Clinical Research & Pharmacovigilance).pptxADR reporting (Clinical Research & Pharmacovigilance).pptx
ADR reporting (Clinical Research & Pharmacovigilance).pptx
Dureshahwar khan
 
DRUG SAFETY REPORTING.pptx
DRUG SAFETY REPORTING.pptxDRUG SAFETY REPORTING.pptx
DRUG SAFETY REPORTING.pptx
Ameena Kadar
 

Similar to ADVERSE EVENT REPORTINGOF MEDICAL DEVICE (20)

Medical device-consumer-workshop
Medical device-consumer-workshopMedical device-consumer-workshop
Medical device-consumer-workshop
 
Safety monitoring and reporting of adverse events of medical devices national...
Safety monitoring and reporting of adverse events of medical devices national...Safety monitoring and reporting of adverse events of medical devices national...
Safety monitoring and reporting of adverse events of medical devices national...
 
Medical device reporting 27 sep2016
Medical device reporting 27 sep2016Medical device reporting 27 sep2016
Medical device reporting 27 sep2016
 
Presentation: Increasing post-market vigilance requirements for medical devices
Presentation: Increasing post-market vigilance requirements for medical devicesPresentation: Increasing post-market vigilance requirements for medical devices
Presentation: Increasing post-market vigilance requirements for medical devices
 
Presentation: Medical Devices: how to stay included workshop - Adverse event ...
Presentation: Medical Devices: how to stay included workshop - Adverse event ...Presentation: Medical Devices: how to stay included workshop - Adverse event ...
Presentation: Medical Devices: how to stay included workshop - Adverse event ...
 
Sponsor Information and Training day Session A3 - Medical Devices: Post-marke...
Sponsor Information and Training day Session A3 - Medical Devices: Post-marke...Sponsor Information and Training day Session A3 - Medical Devices: Post-marke...
Sponsor Information and Training day Session A3 - Medical Devices: Post-marke...
 
Devices Sponsor Information Day: 5 - Post-market - Adverse events and monitor...
Devices Sponsor Information Day: 5 - Post-market - Adverse events and monitor...Devices Sponsor Information Day: 5 - Post-market - Adverse events and monitor...
Devices Sponsor Information Day: 5 - Post-market - Adverse events and monitor...
 
SPONTANEOUS REPORTING SYSTEM & GUIDELINES FOR ADR REPORTING.pptx
SPONTANEOUS REPORTING SYSTEM & GUIDELINES FOR ADR REPORTING.pptxSPONTANEOUS REPORTING SYSTEM & GUIDELINES FOR ADR REPORTING.pptx
SPONTANEOUS REPORTING SYSTEM & GUIDELINES FOR ADR REPORTING.pptx
 
Presentation: Life cycle of medical devices
Presentation: Life cycle of medical devicesPresentation: Life cycle of medical devices
Presentation: Life cycle of medical devices
 
Presentation: Therapeutic Goods Administration: An introduction to the work o...
Presentation: Therapeutic Goods Administration: An introduction to the work o...Presentation: Therapeutic Goods Administration: An introduction to the work o...
Presentation: Therapeutic Goods Administration: An introduction to the work o...
 
Presentation: Patient implant cards and information leaflets – implementation
Presentation: Patient implant cards and information leaflets – implementationPresentation: Patient implant cards and information leaflets – implementation
Presentation: Patient implant cards and information leaflets – implementation
 
PATIENT SAFETY
PATIENT SAFETYPATIENT SAFETY
PATIENT SAFETY
 
Presentation: MMDR reform - Patient Implant Cards and Information Leaflets
Presentation: MMDR reform - Patient Implant Cards and Information LeafletsPresentation: MMDR reform - Patient Implant Cards and Information Leaflets
Presentation: MMDR reform - Patient Implant Cards and Information Leaflets
 
The regulation of medical devices in Australia
The regulation of medical devices in AustraliaThe regulation of medical devices in Australia
The regulation of medical devices in Australia
 
Safety Monitoring and Reporting in Clinical Trials DIA Poster 2015
Safety Monitoring and Reporting in Clinical Trials DIA Poster 2015Safety Monitoring and Reporting in Clinical Trials DIA Poster 2015
Safety Monitoring and Reporting in Clinical Trials DIA Poster 2015
 
Fda med watch
Fda med watchFda med watch
Fda med watch
 
IMPACT OF APPLYING INTERNATIONAL QUALITY STANDARDS ON MEDICAL EQUIPMENT IN SA...
IMPACT OF APPLYING INTERNATIONAL QUALITY STANDARDS ON MEDICAL EQUIPMENT IN SA...IMPACT OF APPLYING INTERNATIONAL QUALITY STANDARDS ON MEDICAL EQUIPMENT IN SA...
IMPACT OF APPLYING INTERNATIONAL QUALITY STANDARDS ON MEDICAL EQUIPMENT IN SA...
 
Postmarket monitoring of therapeutic goods in Australia
Postmarket monitoring of therapeutic goods in AustraliaPostmarket monitoring of therapeutic goods in Australia
Postmarket monitoring of therapeutic goods in Australia
 
ADR reporting (Clinical Research & Pharmacovigilance).pptx
ADR reporting (Clinical Research & Pharmacovigilance).pptxADR reporting (Clinical Research & Pharmacovigilance).pptx
ADR reporting (Clinical Research & Pharmacovigilance).pptx
 
DRUG SAFETY REPORTING.pptx
DRUG SAFETY REPORTING.pptxDRUG SAFETY REPORTING.pptx
DRUG SAFETY REPORTING.pptx
 

Recently uploaded

RHEOLOGY Physical pharmaceutics-II notes for B.pharm 4th sem students
RHEOLOGY Physical pharmaceutics-II notes for B.pharm 4th sem studentsRHEOLOGY Physical pharmaceutics-II notes for B.pharm 4th sem students
RHEOLOGY Physical pharmaceutics-II notes for B.pharm 4th sem students
Himanshu Rai
 
IGCSE Biology Chapter 14- Reproduction in Plants.pdf
IGCSE Biology Chapter 14- Reproduction in Plants.pdfIGCSE Biology Chapter 14- Reproduction in Plants.pdf
IGCSE Biology Chapter 14- Reproduction in Plants.pdf
Amin Marwan
 
NEWSPAPERS - QUESTION 1 - REVISION POWERPOINT.pptx
NEWSPAPERS - QUESTION 1 - REVISION POWERPOINT.pptxNEWSPAPERS - QUESTION 1 - REVISION POWERPOINT.pptx
NEWSPAPERS - QUESTION 1 - REVISION POWERPOINT.pptx
iammrhaywood
 
How to deliver Powerpoint Presentations.pptx
How to deliver Powerpoint  Presentations.pptxHow to deliver Powerpoint  Presentations.pptx
How to deliver Powerpoint Presentations.pptx
HajraNaeem15
 
Chapter wise All Notes of First year Basic Civil Engineering.pptx
Chapter wise All Notes of First year Basic Civil Engineering.pptxChapter wise All Notes of First year Basic Civil Engineering.pptx
Chapter wise All Notes of First year Basic Civil Engineering.pptx
Denish Jangid
 
The History of Stoke Newington Street Names
The History of Stoke Newington Street NamesThe History of Stoke Newington Street Names
The History of Stoke Newington Street Names
History of Stoke Newington
 
Pengantar Penggunaan Flutter - Dart programming language1.pptx
Pengantar Penggunaan Flutter - Dart programming language1.pptxPengantar Penggunaan Flutter - Dart programming language1.pptx
Pengantar Penggunaan Flutter - Dart programming language1.pptx
Fajar Baskoro
 
Leveraging Generative AI to Drive Nonprofit Innovation
Leveraging Generative AI to Drive Nonprofit InnovationLeveraging Generative AI to Drive Nonprofit Innovation
Leveraging Generative AI to Drive Nonprofit Innovation
TechSoup
 
Your Skill Boost Masterclass: Strategies for Effective Upskilling
Your Skill Boost Masterclass: Strategies for Effective UpskillingYour Skill Boost Masterclass: Strategies for Effective Upskilling
Your Skill Boost Masterclass: Strategies for Effective Upskilling
Excellence Foundation for South Sudan
 
What is Digital Literacy? A guest blog from Andy McLaughlin, University of Ab...
What is Digital Literacy? A guest blog from Andy McLaughlin, University of Ab...What is Digital Literacy? A guest blog from Andy McLaughlin, University of Ab...
What is Digital Literacy? A guest blog from Andy McLaughlin, University of Ab...
GeorgeMilliken2
 
Walmart Business+ and Spark Good for Nonprofits.pdf
Walmart Business+ and Spark Good for Nonprofits.pdfWalmart Business+ and Spark Good for Nonprofits.pdf
Walmart Business+ and Spark Good for Nonprofits.pdf
TechSoup
 
BÀI TẬP BỔ TRỢ TIẾNG ANH LỚP 9 CẢ NĂM - GLOBAL SUCCESS - NĂM HỌC 2024-2025 - ...
BÀI TẬP BỔ TRỢ TIẾNG ANH LỚP 9 CẢ NĂM - GLOBAL SUCCESS - NĂM HỌC 2024-2025 - ...BÀI TẬP BỔ TRỢ TIẾNG ANH LỚP 9 CẢ NĂM - GLOBAL SUCCESS - NĂM HỌC 2024-2025 - ...
BÀI TẬP BỔ TRỢ TIẾNG ANH LỚP 9 CẢ NĂM - GLOBAL SUCCESS - NĂM HỌC 2024-2025 - ...
Nguyen Thanh Tu Collection
 
UGC NET Exam Paper 1- Unit 1:Teaching Aptitude
UGC NET Exam Paper 1- Unit 1:Teaching AptitudeUGC NET Exam Paper 1- Unit 1:Teaching Aptitude
UGC NET Exam Paper 1- Unit 1:Teaching Aptitude
S. Raj Kumar
 
BBR 2024 Summer Sessions Interview Training
BBR  2024 Summer Sessions Interview TrainingBBR  2024 Summer Sessions Interview Training
BBR 2024 Summer Sessions Interview Training
Katrina Pritchard
 
How to Make a Field Mandatory in Odoo 17
How to Make a Field Mandatory in Odoo 17How to Make a Field Mandatory in Odoo 17
How to Make a Field Mandatory in Odoo 17
Celine George
 
Beyond Degrees - Empowering the Workforce in the Context of Skills-First.pptx
Beyond Degrees - Empowering the Workforce in the Context of Skills-First.pptxBeyond Degrees - Empowering the Workforce in the Context of Skills-First.pptx
Beyond Degrees - Empowering the Workforce in the Context of Skills-First.pptx
EduSkills OECD
 
How to Create a More Engaging and Human Online Learning Experience
How to Create a More Engaging and Human Online Learning Experience How to Create a More Engaging and Human Online Learning Experience
How to Create a More Engaging and Human Online Learning Experience
Wahiba Chair Training & Consulting
 
Mule event processing models | MuleSoft Mysore Meetup #47
Mule event processing models | MuleSoft Mysore Meetup #47Mule event processing models | MuleSoft Mysore Meetup #47
Mule event processing models | MuleSoft Mysore Meetup #47
MysoreMuleSoftMeetup
 
A Independência da América Espanhola LAPBOOK.pdf
A Independência da América Espanhola LAPBOOK.pdfA Independência da América Espanhola LAPBOOK.pdf
A Independência da América Espanhola LAPBOOK.pdf
Jean Carlos Nunes Paixão
 
Wound healing PPT
Wound healing PPTWound healing PPT
Wound healing PPT
Jyoti Chand
 

Recently uploaded (20)

RHEOLOGY Physical pharmaceutics-II notes for B.pharm 4th sem students
RHEOLOGY Physical pharmaceutics-II notes for B.pharm 4th sem studentsRHEOLOGY Physical pharmaceutics-II notes for B.pharm 4th sem students
RHEOLOGY Physical pharmaceutics-II notes for B.pharm 4th sem students
 
IGCSE Biology Chapter 14- Reproduction in Plants.pdf
IGCSE Biology Chapter 14- Reproduction in Plants.pdfIGCSE Biology Chapter 14- Reproduction in Plants.pdf
IGCSE Biology Chapter 14- Reproduction in Plants.pdf
 
NEWSPAPERS - QUESTION 1 - REVISION POWERPOINT.pptx
NEWSPAPERS - QUESTION 1 - REVISION POWERPOINT.pptxNEWSPAPERS - QUESTION 1 - REVISION POWERPOINT.pptx
NEWSPAPERS - QUESTION 1 - REVISION POWERPOINT.pptx
 
How to deliver Powerpoint Presentations.pptx
How to deliver Powerpoint  Presentations.pptxHow to deliver Powerpoint  Presentations.pptx
How to deliver Powerpoint Presentations.pptx
 
Chapter wise All Notes of First year Basic Civil Engineering.pptx
Chapter wise All Notes of First year Basic Civil Engineering.pptxChapter wise All Notes of First year Basic Civil Engineering.pptx
Chapter wise All Notes of First year Basic Civil Engineering.pptx
 
The History of Stoke Newington Street Names
The History of Stoke Newington Street NamesThe History of Stoke Newington Street Names
The History of Stoke Newington Street Names
 
Pengantar Penggunaan Flutter - Dart programming language1.pptx
Pengantar Penggunaan Flutter - Dart programming language1.pptxPengantar Penggunaan Flutter - Dart programming language1.pptx
Pengantar Penggunaan Flutter - Dart programming language1.pptx
 
Leveraging Generative AI to Drive Nonprofit Innovation
Leveraging Generative AI to Drive Nonprofit InnovationLeveraging Generative AI to Drive Nonprofit Innovation
Leveraging Generative AI to Drive Nonprofit Innovation
 
Your Skill Boost Masterclass: Strategies for Effective Upskilling
Your Skill Boost Masterclass: Strategies for Effective UpskillingYour Skill Boost Masterclass: Strategies for Effective Upskilling
Your Skill Boost Masterclass: Strategies for Effective Upskilling
 
What is Digital Literacy? A guest blog from Andy McLaughlin, University of Ab...
What is Digital Literacy? A guest blog from Andy McLaughlin, University of Ab...What is Digital Literacy? A guest blog from Andy McLaughlin, University of Ab...
What is Digital Literacy? A guest blog from Andy McLaughlin, University of Ab...
 
Walmart Business+ and Spark Good for Nonprofits.pdf
Walmart Business+ and Spark Good for Nonprofits.pdfWalmart Business+ and Spark Good for Nonprofits.pdf
Walmart Business+ and Spark Good for Nonprofits.pdf
 
BÀI TẬP BỔ TRỢ TIẾNG ANH LỚP 9 CẢ NĂM - GLOBAL SUCCESS - NĂM HỌC 2024-2025 - ...
BÀI TẬP BỔ TRỢ TIẾNG ANH LỚP 9 CẢ NĂM - GLOBAL SUCCESS - NĂM HỌC 2024-2025 - ...BÀI TẬP BỔ TRỢ TIẾNG ANH LỚP 9 CẢ NĂM - GLOBAL SUCCESS - NĂM HỌC 2024-2025 - ...
BÀI TẬP BỔ TRỢ TIẾNG ANH LỚP 9 CẢ NĂM - GLOBAL SUCCESS - NĂM HỌC 2024-2025 - ...
 
UGC NET Exam Paper 1- Unit 1:Teaching Aptitude
UGC NET Exam Paper 1- Unit 1:Teaching AptitudeUGC NET Exam Paper 1- Unit 1:Teaching Aptitude
UGC NET Exam Paper 1- Unit 1:Teaching Aptitude
 
BBR 2024 Summer Sessions Interview Training
BBR  2024 Summer Sessions Interview TrainingBBR  2024 Summer Sessions Interview Training
BBR 2024 Summer Sessions Interview Training
 
How to Make a Field Mandatory in Odoo 17
How to Make a Field Mandatory in Odoo 17How to Make a Field Mandatory in Odoo 17
How to Make a Field Mandatory in Odoo 17
 
Beyond Degrees - Empowering the Workforce in the Context of Skills-First.pptx
Beyond Degrees - Empowering the Workforce in the Context of Skills-First.pptxBeyond Degrees - Empowering the Workforce in the Context of Skills-First.pptx
Beyond Degrees - Empowering the Workforce in the Context of Skills-First.pptx
 
How to Create a More Engaging and Human Online Learning Experience
How to Create a More Engaging and Human Online Learning Experience How to Create a More Engaging and Human Online Learning Experience
How to Create a More Engaging and Human Online Learning Experience
 
Mule event processing models | MuleSoft Mysore Meetup #47
Mule event processing models | MuleSoft Mysore Meetup #47Mule event processing models | MuleSoft Mysore Meetup #47
Mule event processing models | MuleSoft Mysore Meetup #47
 
A Independência da América Espanhola LAPBOOK.pdf
A Independência da América Espanhola LAPBOOK.pdfA Independência da América Espanhola LAPBOOK.pdf
A Independência da América Espanhola LAPBOOK.pdf
 
Wound healing PPT
Wound healing PPTWound healing PPT
Wound healing PPT
 

ADVERSE EVENT REPORTINGOF MEDICAL DEVICE

  • 1. ADVERSE EVENT REPORTING OF MEDICAL DEVICES Presented By: Tanisha Jain 2308212170005 > < Guided By: Mrs. Khyati Patel Assistant Professor
  • 2. > < INTRODUCTION ADVERSE EVENT REPORTING OF MEDICAL DEVICE OBJECTIVES ABOUT EVENTS TABLE OF CONTENTS 2
  • 3. > < 3 WHO CAN REPORT? WHOM TO REPORT? TIMING TO REPORT? TIMEFRAME FOR REPORT? MDAE FORM
  • 4. > < INTRODUCTION: Medical Device: A medical device can be any instrument, apparatus, implement, machine, appliance, implant, reagent for in vitro use, software, material or other similar or related article, intended by the manufacturer to be used, alone or in combination for a medical purpose. 4
  • 6. > < INTRODUCTION: Classification of MD (USFDA) Medical Devices Risk-Based Classifications Class I Low Risk Eg: Bandages Class II Moderate Risk Eg: Nebulizers Class III High Risk Eg: Pacemakers 6
  • 7. > < INTRODUCTION: Classification of MD (EU) Medical Devices Risk-Based Classifications Class I Low Risk Eg: Wheelchair Class IIa Moderate Risk Eg: Hearing Aids Class IIb Potential Risk Eg: Infusion Pumps Class III High Risk Eg: Stunt grafts 7
  • 8. > < Adverse Event Reporting of Medical Device:  Adverse Event includes undesirable medical condition that can be symptoms (nausea, chest pain), signs (tachycardia, enlarged liver) or the abnormal results of an investigation (laboratory findings, electrocardiogram).  Adverse Events are not necessarily caused by the medication – the event just needs to have occurred after taking a medicine. 8
  • 9. > < OBJECTIVES: • Importance of monitoring patients for an adverse event. • Identify the common causes of an adverse event. • Review the management of an adverse event. • Review the outcomes for patients affected by an adverse event. 9
  • 10. > < ABOUT EVENTS:  An Event has Occurred The manufacturer becomes aware of information regarding an event which has occurred with its device. 10
  • 11. > < ABOUT EVENTS: Typical events are: a) A malfunction or deterioration in the characteristics or performance. b) An incorrect or out of specification test result. c) The discovery of a design flaw during design review. d) An inaccuracy in the labelling, instructions for use and/or promotional materials. 11
  • 12. > < ABOUT EVENTS:  The Manufacturer’s Device is Associated with the Event. • Complaint trends • History of previous similar events. • Information collected from healthcare professional about the event. 12
  • 13. > < ABOUT EVENTS:  The Event Led to One of the Following Outcomes: • Death of a Patient, User • Serious Injury of a Patient, User • No death or serious injury occurred but the event might lead to death or serious injury of a patient, User or Other Person if the event reoccurs. 13
  • 14. > < ABOUT EVENTS:  Examples of Reportable Events: • Loss of sensing after a pacemaker has reached end of life. • Adverse reaction of an orthopaedic implant due to loosening. • A batch of out-of-specification blood glucose test strips is released. Patient uses strips according to instructions, but readings provide incorrect values leading to incorrect insulin dosage, resulting in hypoglycaemic shock and AE. • Unprotected ECG cable plugged into the main electricity supply – patient died. 14
  • 15. > < WHO CAN REPORT? • All healthcare clinicians, pharmacists, nurses & patients, biomedical/clinical engineers, hospital technology managers /technicians 15
  • 16. > < WHOM TO REPORT? • Adverse Events must be reported to a regulatory Authority according to applicable requirements in each jurisdiction. • Regulatory Authorities should provide a contact point to manufacturers for reporting. 16
  • 17. > < TIMING FOR REPORTING: • All other reportable events must be reported as soon as possible by the manufacturer, but not later than 30-elapsed calendar days following the date of awareness of the event. • If after becoming aware of a potentially reportable adverse event, there is still uncertainty about whether the event is reportable, the manufacturer must submit a report within the timeframe required for that type of event. 17
  • 18. > < TIMING FOR REPORTING: • All report times refer to when the authority must first be notified. • This notification may be in the form of an initial report, final report or trend report as required. • If additional information is required, the manufacturer should provide a follow-up or final report as soon as the information is available or as requested by the authority. 18
  • 19. > < TIMEFRAME FOR REPORTING: 19 Reporter What to Report To Whom When Manufacturers Medical device adverse event (MDAE) or incident on MDAE reporting form with causality assessment report. MvPI Within 30 calendar days of becoming aware of an event. Manufacturers Reports for an event on MDAE reporting form with remedial action to prevent an unreasonable risk of substantial harm to public health. MvPI Within 5 work days of becoming aware of an event. Healthcare service provider Medical device adverse event or incident on MDAE reporting form with causality assessment report. MvPI MDAE reporting form within 5 work days of becoming aware and root cause analysis in next 30 calendar days.
  • 22. > < REFERENCES: 22 GHTF/SG2/N54R8:2006 FINAL DOCUMENT Global Harmonization Task Force Title: Medical Devices Post Market Surveillance: Global Guidance for Adverse Event Reporting for Medical Devices.